Source: Eur Respir J 2006; 28: 939-944
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Albuquerque A. L. P., Nery L. E., Villaca D. S., Machado T. Y. S., Oliveira C. C., Paes A. T., Neder J. A.. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006; 28: 939-944

Member's Comments

No comment yet.

Related content which might interest you: Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Source: Eur Respir J 2012; 40: 322-329 Year: 2012 Physiology and consequences of lung hyperinflation in COPD Source: Eur Respir Rev 2006; 15: 61-67 Year: 2006 Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 86-94 Year: 2004 Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006 Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD Source: Eur Respir J 2004; 24: 385-390 Year: 2004 Mechanisms limiting exercise in COPD: new insights Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease Year: 2005 Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Source: Eur Respir J 2004; 23: 832-840 Year: 2004 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Improving ventilatory mechanics Source: Annual Congress 2005 - Contemporary physiological approaches to reversing the disease spiral in advanced COPD Year: 2005 Effects of pulmonary rehabilitation on operational chest wall volumes during exercise in COPD patients Source: Annual Congress 2006 - Physiological responses to rehabilitation Year: 2006 Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Dyspnoea Source: Respipedia Article Year: 2016 Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001 Positive expiratory pressure therapy improves inspiratory capacity and physical activity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall Source: Eur Respir J 2002; 19: 919-927 Year: 2002 Heliox, dyspnoea and exercise in COPD Source: Eur Respir Rev 2009; 19: 30-38 Year: 2010 Assessment of exercise capacity after lobectomy in patients with COPD Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 Acute effects of inspiratory pressure support during exercise in patients with COPD Source: Eur Respir J 2004; 23: 34-40 Year: 2004 Inspiratory capacity-to-total lung capacity ratio is related to expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Lung function I Year: 2007